The Recall Desk

FDA (Drugs) recall action 87093

Bausch Health Companies, Inc. recalled 2 products on 2021-02-03

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2021-02-03
Critical
0
Units
14,984

Why these products were recalled

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • LowFDA (Drugs)··2021-02-03

    Bausch Health Recalls Mephyton Tablets Due to Impurity D Failure

    Bausch Health is recalling 895 bottles of Mephyton (phytonadione) 5mg tablets because Impurity D failed stability testing specifications.

    Product
    Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC Bridgewater, NJ 08807 USA NDC 0187-1704-05
    Category
    Distribution
    0 states
  • LowFDA (Drugs)··2021-02-03

    Bausch Health Recalls Phytonadione Tablets Due to Impurity D

    Bausch Health is recalling Phytonadione Tablets 5mg because Impurity D exceeded specifications during stability testing. The recall covers 14,089 bottles distributed nationwide.

    Product
    Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30
    Category
    Distribution
    0 states